I-che Chung
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
TGFβ Blockade by Inhibition of Enolase-1-Mediated Plasmin Targets Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma.
Journal: Oncology research
Published: December 19, 2025
Unrevealed roles of extracellular enolase‑1 (ENO1) in promoting glycolysis and pro‑cancer activities in multiple myeloma via hypoxia‑inducible factor 1α.
Journal: Oncology reports
Published: January 14, 2023
Monoclonal enolase-1 blocking antibody ameliorates pulmonary inflammation and fibrosis.
Journal: Respiratory research
Published: November 07, 2022
A Novel Enolase-1 Antibody Targets Multiple Interacting Players in the Tumor Microenvironment of Advanced Prostate Cancer.
Journal: Molecular cancer therapeutics
Published: March 29, 2021
Cbl Negatively Regulates NLRP3 Inflammasome Activation through GLUT1-Dependent Glycolysis Inhibition.
Journal: International journal of molecular sciences
Published: June 15, 2020
Mitochondrial Oxidative Phosphorylation Complex Regulates NLRP3 Inflammasome Activation and Predicts Patient Survival in Nasopharyngeal Carcinoma.
Journal: Molecular & cellular proteomics : MCP
Published: October 05, 2019
EFLA 945 restricts AIM2 inflammasome activation by preventing DNA entry for psoriasis treatment.
Journal: Cytokine
Published: March 19, 2019
Pretreatment with a Heat-Killed Probiotic Modulates the NLRP3 Inflammasome and Attenuates Colitis-Associated Colorectal Cancer in Mice.
Journal: Nutrients
Published: January 31, 2019
Src-family kinase-Cbl axis negatively regulates NLRP3 inflammasome activation.
Journal: Cell death & disease
Published: August 01, 2018
Last Updated: 09/26/2026